JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, vol.30, no.1, pp.135-143, 2013 (SCI-Expanded)
Introduction: This study is a ten years experience of a tertiary care center documenting the data of 132 myasthenia gravis (MG) patients. Our aim is to review retrospectively the clinical and immunological properties and treatment responses of a heterogeneous group of MG patients. Special attention has been focused on two subgroups, thymoma associated MG and pure ocular MG patients.